Dermira Receives $35,000,000 Series B Financing Round

  • Feed Type
  • Date
    6/12/2013
  • Company Name
    Dermira
  • Mailing Address
    2055 Woodside Road Redwood City, CA 94061
  • Company Description
    Dermira is a development-stage, private biotech company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and owns and licenses a robust pipeline of innovative topical compounds addressing areas of need in dermatology. Our lead product candidate, lemuteporfin (LTS), is currently in clinical trials for acne.
  • Website
    http://www.dermira.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    These new funds provide Dermira with the resources required to continue to advance its robust pipeline of novel therapeutics for serious dermatological conditions.
  • M&A Terms
  • Venture Investor
    Maruho
  • Venture Investor
    Bay City Capital
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Canaan Partners

By posting a comment, you agree to our terms and conditions.